Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma

Medulloblastoma is the most common malignant childhood brain tumor, and 5-year overall survival rates are as low as 40% depending on molecular subtype, with new therapies critically important. As radiotherapy and chemotherapy act through the induction of DNA damage, the sensitization of cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Buck, Jessica, Dyer, Patrick J. C., Hii, Hilary, Carline, Brooke, Kuchibhotla, Mani, Byrne, Jacob, Howlett, Meegan, Whitehouse, Jacqueline, Ebert, Martin A., McDonald, Kerrie L., Gottardo, Nicholas G., Endersby, Raelene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116896/
https://www.ncbi.nlm.nih.gov/pubmed/33996894
http://dx.doi.org/10.3389/fmolb.2021.633344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116896/
https://www.ncbi.nlm.nih.gov/pubmed/33996894
http://dx.doi.org/10.3389/fmolb.2021.633344

Ejemplares similares